AstraZeneca buys fish-oils drug maker Omthera
AstraZeneca is spending up to $443m (£293m) to buy a US heart-medicine business in an attempt to resuscitate the drug maker's dwindling pipeline of new products.
The acquisition of Omthera Pharmaceuticals is one of the first big deals for Pascal Soriot, who took the helm at Britain's second-biggest pharmaceuticals company in October and set out a strategy to restock AstraZeneca's drugs cabinet with cardiovascular, cancer, respiratory and inflammation medicines. Omthera Pharmaceuticals uses fish oils to produce treatments for people who are obese, diabetic or suffering from cardiovascular disease, with its big hope being Epanova, a pill aimed at lowering the level of triglycerides, or fats, in the blood.
The medicine has already gone through final-stage clinical trials and is set to be submitted for regulatory approval in the key American market in weeks. A string of AstraZeneca's big-selling drugs fell out of patent last year as revenues fell 17 per cent to £27.9bn.
- 2 Maisie Williams has an excellent message for one confused fan
- 3 There is something wrong but very right about this Bible illustration
- 5 Tampon tax scrapped in Canada after petition convinces conservative government
Saudi Arabia mosque bombing: Two volunteer security guards hailed as heroes for stopping Isis suicide bomber reaching worshippers
Maisie Williams has an excellent message for one confused fan
Archaeologists discover 2,400-year-old gold bongs in Russia
Tampon tax scrapped in Canada after petition convinces conservative government
Migrants in Kos: Photos show real tragedy after British tourists complain of 'awkward' holidays
EU referendum: David Cameron's rules are a 'democratic disgrace', says French-born Scottish politician set to be denied a vote
British tourists complain that impoverished boat migrants are making holidays 'awkward' in Kos
A nation of inequality: How the UK is failing to feed its most vulnerable people
Australian man punched in the face for defending Muslim women from abuse on train
Migrants in Kos: Photos show real tragedy after Brits abroad complain of 'awkward' holidays
EU referendum: David Cameron to deny EU migrants and under-18s the chance to vote
iJobs Money & Business
£30 - 35k: Guru Careers: We are seeking a Pricing Analyst to join a leading e-...
£20000 - £25000 per annum + OTE £45K YR1: SThree: At SThree, we like to be dif...
£20000 - £25000 per annum + competitive: SThree: Did you know? SThree is a mul...
£55 - 65k (DOE): Guru Careers: A unique opportunity for a permanent C# Develop...